Buyback Spend for Moderna (MRNA)
Buyback Spend for Moderna (MRNA): headline value $0. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingBuyback SpendSwitch metric
Latest period
$0
YoY change
N/A
5Y CAGR
N/A
Peak year (2022)
$3.33B
Latest annual
$0
Buyback Spend history chart for Moderna (MRNA) from 2016 to 2025
Buyback Spend history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $0 | — | ||
| 2024 | $0 | -100.0% | ||
| 2023 | $1.15B | -65.4% | ||
| 2022 | $3.33B | +288.4% | ||
| 2021 | $857.00M | — | ||
| 2020 | $0 | -100.0% | ||
| 2019 | $2.89M | -64.7% | ||
| 2018 | $8.18M | — | ||
| 2017 | $0 | — | ||
| 2016 | $0 | — |
Buyback Spend values are taken from Moderna's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Moderna (MRNA) buyback spend totalled $0.
Moderna buyback spend peaked at $3.33B in 2022; the latest annual figure is $0 in 2025 (100.0% below peak).
The highest annual buyback spend of $3.33B was reported in 2022. The lowest in the available history was $0 in 2016.
Within Healthcare, Moderna (MRNA) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
Moderna Buyback Spend by Year
Moderna Buyback Spend 2025: $0
Moderna buyback spend in 2025 was $0.
Moderna Buyback Spend 2024: $0
Moderna buyback spend in 2024 was $0, plunged 100.0% below 2023.
Moderna Buyback Spend 2023: $1.15B
Moderna buyback spend in 2023 was $1.15B, plunged 65.4% below 2022.
Moderna Buyback Spend 2022: $3.33B
Moderna buyback spend in 2022 was $3.33B, surged 288.4% from 2021. This figure represents the highest annual value in the available history.
Moderna Buyback Spend 2021: $857.00M
Moderna buyback spend in 2021 was $857.00M.
See more financial history for Moderna (MRNA).
Sector peers — Buyback Spend
Companies in the same sector as Moderna, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is Moderna's buyback spend?
Latest reported buyback spend for Moderna (MRNA) is $0 (period ending December 31, 2025).
When did Moderna buyback spend hit its highest annual value?
Moderna buyback spend reached its highest annual value of $3.33B in 2022.
What was Moderna buyback spend in 2024?
Moderna (MRNA) buyback spend in 2024 was $0.
What was Moderna buyback spend in 2025?
Moderna (MRNA) buyback spend in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.